In light of this, we assessed the efficacy and drug concentrations of CZP and ADA in patients with RA stratified by RF level at baseline in a post hoc analysis of the EXXELERATE study (a head-to-head trial which compared CZP to ADA). Here, ADA is linked to rheumatoid arthritis.